Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Anna Muscarella

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Lung Cancer Management|January 16, 2019
<i>NRG1</i>: a cinderella fusion in lung cancer?Lucia Anna Muscarella, Antonio Rossi
International Journal of Molecular Sciences|December 17, 2024
Tumor Methylation Burden (TMeB) in Non-Small Cell Lung Cancer: A New Way of Thinking About EpigeneticsFederico Pio Fabrizio, Lucia Anna Muscarella
Med (New York, N.Y.)|April 12, 2025
eNRGy: Making progress toward a future for NRG1 fusion-positive cancerLucia Anna Muscarella, Massimo Di Maio
Journal of Thoracic Disease|February 3, 2017
Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?Lucia Anna Muscarella, Vito Michele Fazio
Frontiers in Oncology|July 10, 2023
Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLCUmberto Malapelle, Fabrizio Tabbò, Lucia Anna Muscarella
Future Oncology (London, England)|January 5, 2021
<i>NRG</i> fusions in tumors: moving from the past to future knowledgeDomenico Trombetta, Angelo Sparaneo, Lucia Anna Muscarella
Cancers|December 8, 2020
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way ForwardFederico Pio Fabrizio, Angelo Sparaneo, Lucia Anna Muscarella
Translational Oncology|October 21, 2023
B7-H3/CD276 and small-cell lung cancer: What's new?Federico Pio Fabrizio, Lucia Anna Muscarella, Antonio Rossi
Oxidative Medicine and Cellular Longevity|November 17, 2016
Nrf2 and Notch Signaling in Lung Cancer: Near the CrossroadAngelo Sparaneo, Federico Pio Fabrizio, Lucia Anna Muscarella
Frontiers in Oncology|May 8, 2023
Monitoring <i>EGFR</i>-lung cancer evolution: a possible beginning of a "methylation era" in TKI resistance predictionFederico Pio Fabrizio, Angelo Sparaneo, Lucia Anna Muscarella
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Lung Cancer Management|January 16, 2019
<i>NRG1</i>: a cinderella fusion in lung cancer?Lucia Anna Muscarella, Antonio Rossi
International Journal of Molecular Sciences|December 17, 2024
Tumor Methylation Burden (TMeB) in Non-Small Cell Lung Cancer: A New Way of Thinking About EpigeneticsFederico Pio Fabrizio, Lucia Anna Muscarella
Med (New York, N.Y.)|April 12, 2025
eNRGy: Making progress toward a future for NRG1 fusion-positive cancerLucia Anna Muscarella, Massimo Di Maio
Journal of Thoracic Disease|February 3, 2017
Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?Lucia Anna Muscarella, Vito Michele Fazio
Frontiers in Oncology|July 10, 2023
Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLCUmberto Malapelle, Fabrizio Tabbò, Lucia Anna Muscarella
Future Oncology (London, England)|January 5, 2021
<i>NRG</i> fusions in tumors: moving from the past to future knowledgeDomenico Trombetta, Angelo Sparaneo, Lucia Anna Muscarella
Cancers|December 8, 2020
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way ForwardFederico Pio Fabrizio, Angelo Sparaneo, Lucia Anna Muscarella
Translational Oncology|October 21, 2023
B7-H3/CD276 and small-cell lung cancer: What's new?Federico Pio Fabrizio, Lucia Anna Muscarella, Antonio Rossi
Oxidative Medicine and Cellular Longevity|November 17, 2016
Nrf2 and Notch Signaling in Lung Cancer: Near the CrossroadAngelo Sparaneo, Federico Pio Fabrizio, Lucia Anna Muscarella
Frontiers in Oncology|May 8, 2023
Monitoring <i>EGFR</i>-lung cancer evolution: a possible beginning of a "methylation era" in TKI resistance predictionFederico Pio Fabrizio, Angelo Sparaneo, Lucia Anna Muscarella
Pageof 10